Complejo Hospitalario Universitario de Vigo

Vigo, Pontevedra 36312

0 studies enrolling now · 2 studies all time

What they study most

First Line Non-Small Cell Lung Cancer, Multiple Sclerosis, Primary Progressive

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis — Running, not enrolling
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed